Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O N Witte

Showing results (141-150 of 211) with videos related to

Pageof 22
Sort By:
Leukemia|December 1, 1989
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemiaV Najfeld, J Cuttner, A Figur, et al.
Science (New York, N.Y.)|October 30, 1992
A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42HsM J Hart, Y Maru, D Leonard, et al.
Cell|March 1, 1983
Differentiation of cloned populations of immature B cells after transformation with Abelson murine leukemia virusC A Whitlock, S F Ziegler, L J Treiman, et al.
Science (New York, N.Y.)|July 11, 1986
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid geneY Ben-Neriah, G Q Daley, A M Mes-Masson, et al.
Oncogene|September 7, 1995
The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequenceM Kurokawa, S Ogawa, T Tanaka, et al.
Leukemia|December 9, 1998
Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selectionS Mahlmann, J McLaughlin, D E Afar, et al.
Molecular and Cellular Biology|September 1, 1986
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cellsR C Schwartz, L W Stanton, S C Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alterationJ B Konopka, S M Watanabe, J W Singer, et al.
Journal of Virology|March 1, 1986
Monoclonal antibodies specific for v-abl- and c-abl-encoded moleculesL Schiff-Maker, M C Burns, J B Konopka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reactionC L Sawyers, L Timson, E S Kawasaki, et al.
Pageof 22

Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
Leukemia|December 1, 1989
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemiaV Najfeld, J Cuttner, A Figur, et al.
Science (New York, N.Y.)|October 30, 1992
A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42HsM J Hart, Y Maru, D Leonard, et al.
Cell|March 1, 1983
Differentiation of cloned populations of immature B cells after transformation with Abelson murine leukemia virusC A Whitlock, S F Ziegler, L J Treiman, et al.
Science (New York, N.Y.)|July 11, 1986
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid geneY Ben-Neriah, G Q Daley, A M Mes-Masson, et al.
Oncogene|September 7, 1995
The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequenceM Kurokawa, S Ogawa, T Tanaka, et al.
Leukemia|December 9, 1998
Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selectionS Mahlmann, J McLaughlin, D E Afar, et al.
Molecular and Cellular Biology|September 1, 1986
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cellsR C Schwartz, L W Stanton, S C Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alterationJ B Konopka, S M Watanabe, J W Singer, et al.
Journal of Virology|March 1, 1986
Monoclonal antibodies specific for v-abl- and c-abl-encoded moleculesL Schiff-Maker, M C Burns, J B Konopka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reactionC L Sawyers, L Timson, E S Kawasaki, et al.
Pageof 22